The Phase 1b study is designed to evaluate the safety and tolerability of orally administered balomenib over a 28-day treatment period, followed by a post-treatment observation phase of up to ...
A recent study found a substantial time-dependent decrease in acute blood glucose levels (FBS and PPBS) in patients with type ...
Because of NextCell’s algorithm that allows optimized donor choice for MSC production, its therapy could be completely ...
You can develop high blood sugar (hyperglycemia) with type 2 diabetes. This may mean you need to work with your doctor to update your diabetes care plan, consider insulin, or adjust your medications.
Patients with type 1 diabetes mellitus or type 2 diabetes mellitus (T2DM) have an increased risk of fractures; BMD underestimates this risk in individuals with T2DM, making risk assessment challenging ...
By Tashi McQueenAFRO Staff [email protected] Type 2 diabetes mellitus (T2DM) is a chronic, life-altering condition affecting more than 35 million Americans. The disease occurs when a person’s ...
Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.
In a large household cohort, diabetes mellitus in TB patients did not increase tuberculin skin test infection and was linked ...
News-Medical.Net on MSN
Gestational diabetes alters the placenta at the molecular level, study reveals
Gestational diabetes can cause a multitude of complications in the offspring, but to date, the reasons are incompletely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results